Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Karas Eric | Chief Commercial Off | S - Sale+OE | $14.04 | -10.0K | 5,693 | -64% | -$140.4K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $1.50 | +10.0K | 9,410 | New | +$15.0K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Karas Eric | Chief Commercial Off | M - OptEx | $0.00 | -10.0K | 584.6K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-04 | S | D | 6,283 | $14.00 | 5,693 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-04 | M | A | 6,283 | $1.50 | 11,976 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-02 | S | D | 3,717 | $14.11 | 5,693 | D | — | — | (F2) The weighted average sale price for the transaction reported was $14.1139, and the range of prices were between $14.00 and $14.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Common | Common Stock | 2024-12-02 | M | A | 3,717 | $1.50 | 9,410 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 3,717 | $0.00 | 590,871 | D | $1.50 · — to 2032-05-23 | 3,717 Common Stock | (F3) Immediately exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-12-04 | M | D | 6,283 | $0.00 | 584,588 | D | $1.50 · — to 2032-05-23 | 6,283 Common Stock | (F3) Immediately exercisable. |